Biochemical and immunohistochemical study on physiological activity and distribution of hepatic cathepsin D

Acta Physiologica Hungarica

Volumn 90, Issue 1, 2003, Pages 47-56

  Burdan, F ^a   Szumiøo, Justyna ^a   Korobowicz, Agnieszka ^a   Dudka, J ^a   Korobowicz, Elzbieta ^a   Wallner, G ^a   Maciejewski, Ryszard ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cathepsin D; Kupffer cell; Liver, Browicz Kupffer cell; Lysosomal enzymes; Rat

Indexed keywords

CATHEPSIN D; PROTEINASE;

AGE; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER; MALE; MICROSCOPY; NONHUMAN; RAT; SPECTROPHOTOMETRY; TISSUE DISTRIBUTION;

ANIMALS; CATHEPSIN D; IMMUNOHISTOCHEMISTRY; LIVER; MALE; RATS; RATS, WISTAR; STAINING AND LABELING; TISSUE DISTRIBUTION;

EID: 0037234813     PISSN: 0231424X     EISSN: None     Source Type: Journal    
DOI: 10.1556/APhysiol.90.2003.1.6     Document Type: Article

References (37)

1. Ansorge S, Wideranders B, Riemann S, Brouwer A, Knook DL: Distribution of thiol-protein disulfide oxidoreductase, insulin-glucagon and cathepsin D in different cell types of the rat liver. Biomed. Biochim. Acta 43, 1213-1221 (1984)
2. Augereau P, Garcia M, Mattei MG, Cavailles V, Depadova F, Derocq D, Capony F, Ferrara P, Rochefort H: Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11. Mol. Endocrinol. 2, 186-192 (1988)
3. Barrett AJ (1972): Lysosomal enzymes. In: Lysosomes. A Laboratory Handbook, eds. Dingle JH, North-Holland Publ. Co., Amsterdam, pp. 45-135.
4. Burdan F, Burak B, Burski K, Rucinski P, Pliszczynska M: Activity of cathepsins and morphological changes in the rat's liver after ranitidine and famotidine administration. Ann. Univ. Mariae Curie Sklodowska [Med], 54, 299-302 (1999)
5. Burdan F, Siezieniewska Z, Maciejewski R, Madej B, Radzikowska E, Wojtowicz Z: Hepatic lysosomal enzymes activity and liver morphology after short-time omeprazole administration. Exp. Toxic. Pathol. 53, 453-459 (2002)
6. Burdan F, Siezieniewska Z, Maciejewski Z, Burski K, Wojtowicz Z: Temporary elevation of pancreatic lysosomal enzymes, as a result of the omeprazole-induced paripancreatic inflammation in male Wistar rats. J. Physiol. Pharmacol. 51, 463-470 (2000)
7. Cavailles V, Augereau P, Rochefort H: Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc. Natal. Acad. Sci. USA 90, 203-207 (1993)
8. Copony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H: Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res. 49, 3904-3909 (1989)
9. Cybulski M, Berbec H: The role of cathepsin D in cancer progression. Post. Bioch. 47, 224-231 (2001)
10. De Duve C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F: Tissue fractionation studies. 6. Intracellular disribution of enzymes in rat-liver tissue. Bichem. J. 60, 604-617 (1955)
11. Deussing J, Roth W, Saftig P, Peters C, Ploegh HL, Villadangos JA: Cathepsin B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Asoc. Sci. USA 98, 4516-4521 (1998)
12. Ferren LG, Strauber WT, Kalnitsky G: Differential centrifugation studies of guinea pig lung protease. Proc. Soc. Exp. Biol. Med. 159, 239-244 (1978)
13. Gorska P: Principles in laboratory animals research for experimental purpose. Med. Sci. Monit. 6, 171-180 (2000)
14. Knook DL: The role of lysosomal enzymes in protein degradation in different types of rat liver cells. Acta Biol. Med. Chem. 36, 1747-1752 (1977)
15. Kute TE, Grondahl-Hansen J, Shao SM, Long R, Russell G, Brunner N: Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosoles defines up of node negative breast cancer patients with low risk of recurrence. Breast Cancer Res. Treat. 47, 9-16 (1998)
16. Lah TT, Kos J: Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol. Chem. 379, 125-130 (1998)
17. Lemansky P, Gieselmann V, Hasilik A, von Figura K: Cathepsin D and beta-hexosaminidase synthesized in the presence of 1-deoxynojirimycin accumulate in the endoplasmic reticulum. J. Biol. Chem. 259, 10129-10135 (1984)
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with folin phenol reagent. J. Biol. Chem. 193, 265-275 (1951)
19. Maciejewski R, Burdan F, Hermanowicz-Dryka T, Wojcik K, Wojtowicz Z: Changes in the activity of some lysosomal enzymes and in the fine structure of submandibular gland due to experimental diabetes. Acta Physiol. Hung. 86, 127-137 (1999)
20. Maciejewski R. Burski K, Baj J. Madej B. Burdan F, Dabrowski A, Brakowiecki F: Changes in pancreatic lysosomal enzymes activity as the potential factors leading to diabetic enteropathy. J. Physiol. Pharmacol. 52, 823-834 (2001)
21. Maciejewski R, Kaus M, Wojtowicz Z, Burdan F, Burski K: Changes in the activity of pancreatic cathepsin D, L and acid phosphatase in the course of alloxan-induced diabetes mellitus in rabbits. Med. Sci. Res. 28, 113-116 (2000)
22. Maguchi S, Taniguchi N, Makita A: Elevated activity and increased mannose-6-phosphate in the carbohydrate moiety of cathepsin D from human hepatoma. Cancer Res. 48, 362-367 (1988)
23. Maudelonde T, Martinez P, Brouillet JP, Laffargue F, Pages A, Rochefort H: Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker. J. Clin. Endocrinol. Metab. 70, 115-121 (1990)
24. Novocastra Laboratories. Table of cross-reactivities. Novocastra Laboratories Ltd, Newcastle upon Tyne. 2002.
25. Olszewska D, Drewa T, Markiewicz R, Drewa J, Wozniak A, Maciak R: The significance of cathepsin B and D in the physiological and pathological processes. Pol. Merkuriusz Lek. 10, 65-70 (2001)
26. Paris A, Strukey B, Pungercar J, Renko M, Dolenc I, Turk V: Molecular cloning and sequence analysis of human preprocathepsin C. FEBS Lett. 369, 326-330 (1995)
27. Press E, Porter RR, Cebra J: Isolation and properities of a proteolytic enzyme, cathepsin D, from bovine spleen. Biochem. J. 74, 501-514 (1960)
28. Redecker B, Heckendorf B, Grosch HW, Mersmann G, Hasilik A: Molecular organization of the human cathepsin D gene. DNA Cell Biol. 10, 423-431 (1991)
29. Rochefort H: Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. Clin. Chim. Acta 291, 157-170 (2000)
30. Rochefort H, Liaudet-Coopman E: Cathepsin D in cancer metastasis: a protease and a ligand. APMIS 107, 86-95 (1999)
31. Sapolsky A, Woessner JF Jr: Multiple forms of cathepsin D from bovine uterus. J. Biol. Chem. 247, 2069-2076 (1974)
32. Sheikh MS, Augereau P, Chalbos D, Garcia M, Rochefort H: Retinoid regulation of human cathepsin D gene expression. J. Steroid. Biochem. Mol. Biol. 57, 283-291 (1996)
33. Soderstrom M, Salminen H, Glumoff V, Kirschke H, Aro H, Vuorio E: Cathepsin expression during skeletal development. Biochim. Biophys. Acta 1446, 35-46 (1999)
34. Tsukuba T, Okamoto K, Yasuda Y, Morikawa W, Nakanishi H, Yamamoto K: New functional aspects of cathepsin D and cathepsin E. Mol. Cells. 31, 601-611 (2000)
35. Wang F, Duan R, Chirgwin J, Safe SH: Transcriptional activation of cathepsin D gene expression by growth factors. J. Mol. Endocrinol. 24, 193-202 (2000)
36. Worowski K, Ostrowska H: Cathepsin D. Post. Biol. Kom. 7, 119-147 (1980)
37. Yokota S, Tsuji H, Kato K: Localization of cathepsin D in rat liver. Immunocytochemical study using post-embedding immunoenzyme and protein A-gold techniques. Histochemistry 82, 141-148 (1985)